(Q35935868)

11 August 2017

1 reference

title

Murine models for the study of congestive heart failure: Implications for understanding molecular mechanisms and for drug discovery (English)

1 reference

11 August 2017

0 references

congestive heart failure

1 reference

1 reference

1 reference

Qing-Dong Wang

1

1 reference

11 August 2017

Mohammad Bohlooly-Y

series ordinal

2

1 reference

11 August 2017

Per-Ove Sjöquist

series ordinal

3

1 reference

11 August 2017

language of work or name

1 reference

1 November 2004

1 reference

Journal of Pharmacological and Toxicological Methods

11 August 2017

published in

1 reference

11 August 2017

volume

50

1 reference

11 August 2017

issue

3

1 reference

11 August 2017

page(s)

163-174

1 reference

Targeting the receptor-Gq interface to inhibit in vivo pressure overload myocardial hypertrophy

11 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2004.05.005

Dilated cardiomyopathy and sudden death resulting from constitutive activation of protein kinase a.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2004.05.005

MLP-deficient mice exhibit a disruption of cardiac cytoarchitectural organization, dilated cardiomyopathy, and heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2004.05.005

Targeted overexpression of the sarcoplasmic reticulum Ca2+-ATPase increases cardiac contractility in transgenic mouse hearts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2004.05.005

Progressive heart failure after myocardial infarction in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2004.05.005

Increased protein kinase C activity and expression of Ca2+-sensitive isoforms in the failing human heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2004.05.005

Formation of germ-line chimaeras from embryo-derived teratocarcinoma cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2004.05.005

Melusin, a muscle-specific integrin beta1-interacting protein, is required to prevent cardiac failure in response to chronic pressure overload

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2004.05.005

Loss of SR-BI expression leads to the early onset of occlusive atherosclerotic coronary artery disease, spontaneous myocardial infarctions, severe cardiac dysfunction, and premature death in apolipoprotein E-deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2004.05.005

Feedback inhibition of catecholamine release by two different alpha2-adrenoceptor subtypes prevents progression of heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2004.05.005

Extracellular protease activation and unraveling of the myocardial interstitium: critical steps toward clinical applications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2004.05.005

The heart failure epidemic: exactly how big is it?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2004.05.005

Sympathetic nervous system in heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2004.05.005

Cardiac compartment-specific overexpression of a modified retinoic acid receptor produces dilated cardiomyopathy and congestive heart failure in transgenic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2004.05.005

Deficiency of TIMP-1 exacerbates LV remodeling after myocardial infarction in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2004.05.005

Transgenic Galphaq overexpression induces cardiac contractile failure in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2004.05.005

Interactions between phospholamban and beta-adrenergic drive may lead to cardiomyopathy and early mortality

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2004.05.005

Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2004.05.005

Progressive hypertrophy and heart failure in beta1-adrenergic receptor transgenic mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2004.05.005

Genetic alterations that inhibit in vivo pressure-overload hypertrophy prevent cardiac dysfunction despite increased wall stress.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2004.05.005

Heart failure and greater infarct expansion in middle-aged mice: a relevant model for postinfarction failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2004.05.005

Targeted developmental overexpression of calmodulin induces proliferative and hypertrophic growth of cardiomyocytes in transgenic mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2004.05.005

Superinhibition of sarcoplasmic reticulum function by phospholamban induces cardiac contractile failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2004.05.005

Cardiac beta ARK1 inhibition prolongs survival and augments beta blocker therapy in a mouse model of severe heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2004.05.005

Targeted deletion of MMP-2 attenuates early LV rupture and late remodeling after experimental myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2004.05.005

Overexpression of the rat sarcoplasmic reticulum Ca2+ ATPase gene in the heart of transgenic mice accelerates calcium transients and cardiac relaxation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2004.05.005

Loss of a gp130 cardiac muscle cell survival pathway is a critical event in the onset of heart failure during biomechanical stress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2004.05.005

Continuous activation of gp130, a signal-transducing receptor component for interleukin 6-related cytokines, causes myocardial hypertrophy in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2004.05.005

Mixed signals in heart failure: cancer rules

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2004.05.005

Minimally invasive aortic banding in mice: effects of altered cardiomyocyte insulin signaling during pressure overload

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2004.05.005

Ventricular expression of a MLC-2v-ras fusion gene induces cardiac hypertrophy and selective diastolic dysfunction in transgenic mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2004.05.005

Transgenic expression of sarcoplasmic reticulum Ca(2+) atpase modifies the transition from hypertrophy to early heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2004.05.005

Adverse effects of chronic endogenous sympathetic drive induced by cardiac GS alpha overexpression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2004.05.005

Regulation of Ca2+ signaling in transgenic mouse cardiac myocytes overexpressing calsequestrin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2004.05.005

Functional consequences of altering myocardial adrenergic receptor signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2004.05.005

Cardiac function in mice overexpressing the beta-adrenergic receptor kinase or a beta ARK inhibitor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2004.05.005

Dilated cardiomyopathy in transgenic mice with cardiac-specific overexpression of tumor necrosis factor-alpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2004.05.005

Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2004.05.005

Early and delayed consequences of beta(2)-adrenergic receptor overexpression in mouse hearts: critical role for expression level

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2004.05.005

Calcium-dependent arrhythmias in transgenic mice with heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2004.05.005

Targeted ablation of the phospholamban gene is associated with markedly enhanced myocardial contractility and loss of beta-agonist stimulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2004.05.005

The molecular genetic basis for hypertrophic cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2004.05.005

PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2004.05.005

An experimental model for congestive heart failure after encephalomyocarditis virus myocarditis in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2004.05.005

New therapeutic options in congestive heart failure: Part I.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2004.05.005

New therapeutic options in congestive heart failure: Part II.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2004.05.005

Transient cardiac expression of constitutively active Galphaq leads to hypertrophy and dilated cardiomyopathy by calcineurin-dependent and independent pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2004.05.005

Myocardial expression of a constitutively active alpha 1B-adrenergic receptor in transgenic mice induces cardiac hypertrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2004.05.005

Chronic phospholamban-sarcoplasmic reticulum calcium ATPase interaction is the critical calcium cycling defect in dilated cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2004.05.005

A calcineurin-dependent transcriptional pathway for cardiac hypertrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2004.05.005

A Ca(2+)-dependent transgenic model of cardiac hypertrophy: A role for protein kinase Calpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2004.05.005

Left ventricular pressure-volume relationship in a murine model of congestive heart failure due to acute viral myocarditis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2004.05.005

Overexpression of angiotensin II type I receptor in cardiomyocytes induces cardiac hypertrophy and remodeling.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2004.05.005

Impaired cardiac performance in heterozygous mice with a null mutation in the sarco(endo)plasmic reticulum Ca2+-ATPase isoform 2 (SERCA2) gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2004.05.005

Conditional expression of a Gi-coupled receptor causes ventricular conduction delay and a lethal cardiomyopathy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2004.05.005

Expression of a beta-adrenergic receptor kinase 1 inhibitor prevents the development of myocardial failure in gene-targeted mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2004.05.005

Seven-transmembrane-spanning receptors and heart function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2004.05.005

Segregation of atrial-specific and inducible expression of an atrial natriuretic factor transgene in an in vivo murine model of cardiac hypertrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2004.05.005

Cardiac-specific overexpression of RhoA results in sinus and atrioventricular nodal dysfunction and contractile failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2004.05.005

Cardiac-specific overexpression of mouse cardiac calsequestrin is associated with depressed cardiovascular function and hypertrophy in transgenic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2004.05.005

Rescue of contractile parameters and myocyte hypertrophy in calsequestrin overexpressing myocardium by phospholamban ablation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2004.05.005

A new model of congestive heart failure in the mouse due to chronic volume overload

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2004.05.005

Dilated cardiomyopathy and heart failure caused by a mutation in phospholamban

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2004.05.005

The Genetic Basis for Cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2004.05.005

Cardiac myocyte-specific excision of the beta1 integrin gene results in myocardial fibrosis and cardiac failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2004.05.005

Strain-specific patterns of autonomic nervous system activity and heart failure susceptibility in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2004.05.005

Rescue of cardiomyocyte dysfunction by phospholamban ablation does not prevent ventricular failure in genetic hypertrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2004.05.005

Myocardial matrix degradation and metalloproteinase activation in the failing heart: a potential therapeutic target

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2004.05.005

Dance band on the Titanic: biomechanical signaling in cardiac hypertrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2004.05.005

Altered focal adhesion regulation correlates with cardiomyopathy in mice expressing constitutively active rac1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2004.05.005

Genetic modifier loci affecting survival and cardiac function in murine dilated cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2004.05.005

Transgenic overexpression of constitutively active protein kinase C epsilon causes concentric cardiac hypertrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2004.05.005

Altered expression of beta-adrenergic receptor kinase and beta 1-adrenergic receptors in the failing human heart.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2004.05.005

Expression of beta-arrestins and beta-adrenergic receptor kinases in the failing human heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2004.05.005

Morphometric study of myocardial changes during doxorubicin-induced cardiomyopathy in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2004.05.005

Targeted overexpression of protein kinase C beta2 isoform in myocardium causes cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2004.05.005

Absence of pressure overload induced myocardial hypertrophy after conditional inactivation of Gαq/Gα11 in cardiomyocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2004.05.005

Oestrogen protects FKBP12.6 null mice from cardiac hypertrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2004.05.005

FKBP12.6-mediated stabilization of calcium-release channel (ryanodine receptor) as a novel therapeutic strategy against heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2004.05.005

The genetic basis for cardiomyopathy: from mutation identification to mechanistic paradigms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2004.05.005

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VASCN.2004.05.005

1 reference

11 August 2017

1 reference